Its starting
The dermatology community apparently was a little slow to know about and respond to the implications of the Cares Act. Its starting to make sense why a broader segment of investors haven't figured it out - the Dermatologists are just hearing about it as we speak. Looks like there is plenty of unexplored runway to generate some awareness on the importance of TFC 1067. Hopefully we will get some form of notable mention by Rodan of the importance of the product when they decide to launch. For the life of me I can't figure out why Sirona is not shouting from the rooftops at the community to generate draw here. I guess the Rodan launch will be just as much of a market introduction for them as it will be for Sirona. Where is the Hydroquinone? Regulatory Change Hinders Access / OCTOBER 29, 2020 https://practicaldermatology.com/news/where-is-the-hydroquinone-regulatory-change-hinders-access?c4src=home:feed "Changes to FDA regulations implemented as part of the CARES Act this spring have left dermatologists and their patients scrambling to access hydroquinone."